Similarly, the suppressive function of Tregs from patients with MIS-C Tregs was profoundly deficient compared with that of Tregs from healthy controls, which was corrected upon treatment of the cells with anti-CD22 mAb (Figure 6E). The gene discussed is CD22; the disease is COVID-19–associated multisystem inflammatory syndrome in children.